134 related articles for article (PubMed ID: 15507528)
1. PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12.
Liu A; Arbiser JL; Holmgren A; Klein G; Klein E
Blood; 2005 Feb; 105(4):1606-13. PubMed ID: 15507528
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood-derived mononuclear cell cultures.
Liu A; Claesson HE; Mahshid Y; Klein G; Klein E
Blood; 2008 Mar; 111(5):2693-703. PubMed ID: 18094330
[TBL] [Abstract][Full Text] [Related]
3. SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK.
Liu A; Klein G; Bandobashi K; Klein E; Nagy N
Immunol Lett; 2002 Mar; 80(3):181-8. PubMed ID: 11803050
[TBL] [Abstract][Full Text] [Related]
4. Activation of innate immunity by the leukotriene B 4 inhibits EBV induced B-cell transformation in cord-blood derived mononuclear cultures.
Klein E; Liu A; Claesson HE
Immunol Lett; 2008 Mar; 116(2):174-7. PubMed ID: 18241933
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
6. Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes.
Pekkari K; Avila-Cariño J; Bengtsson A; Gurunath R; Scheynius A; Holmgren A
Blood; 2001 May; 97(10):3184-90. PubMed ID: 11342447
[TBL] [Abstract][Full Text] [Related]
7. Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK.
Pekkari K; Goodarzi MT; Scheynius A; Holmgren A; Avila-Cariño J
Blood; 2005 Feb; 105(4):1598-605. PubMed ID: 15494431
[TBL] [Abstract][Full Text] [Related]
8. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
9. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
[TBL] [Abstract][Full Text] [Related]
10. Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus.
Hanley PJ; Lam S; Shpall EJ; Bollard CM
J Vis Exp; 2012 May; (63):e3627. PubMed ID: 22588077
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
[TBL] [Abstract][Full Text] [Related]
14. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
15. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
18. The regulation and biological activity of interleukin 12.
Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
[TBL] [Abstract][Full Text] [Related]
19. Routine detection of Epstein-Barr virus specific T-cells in the peripheral blood by flow cytometry.
Crucian BE; Stowe RP; Pierson DL; Sams CF
J Immunol Methods; 2001 Jan; 247(1-2):35-47. PubMed ID: 11150535
[TBL] [Abstract][Full Text] [Related]
20. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
Nemerow GR; McNaughton ME; Cooper NR
J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
